Abstract: This paper reports on the LGX fluorometric test for enzymatic MRSA/MSSA detection. It highlights the reasons rhodamines have been overlooked and also strategies to improve the synthesis of rhodamine-peptide conjugates. Evaluation of the LGX test for detection of MRSA/MSSA on surfaces is undertaken in the presence of potentially confounding E. coli and S. epidermidis for the first time.
Introduction
The growth in the number of infections caused by antibiotic resistant pathogens has prompted healthcare agencies around the world to generate strategic plans. 1 These plans incorporate the restriction of antibiotic use to slow the emergence of resistant pathogens, as well as the development of new antibiotics, to which resistance will inevitably emerge. The former part of this strategy requires rapid, affordable diagnostics to determine the best clinical course of action. 2 The principle drawbacks of PCR are the laboratory requirements and the expense of each test. This drawback is demonstrated in the UK insofar that PCR is not routinely used to detect problem pathogens such as MRSA.
Bacterial culture is time-consuming (48-72hrs) and as reported in the NHS NOW report specifically concerning MRSA, it is often the case that patients are discharged before the results of the test are known. 3 PCR techniques rely upon the enzymatic amplification of a gene until sufficient quantities can be detected.
Bacterial culture relies upon the growth rate of a bacteria, augmented by the best media. An alternative approach involves the targeting of enzymes expressed by bacteria, which cleave between specific amino acid sequences. 4 To observe the actions of bacterially expressed enzymes and in common with other detection methods, a chromogenic response is arguably the most useful. This is evidenced by the recently reported rhodamine based Rhodamine 110 (2) represents one of the most active fluorophores known, with a high extinction coefficient and a fluorescence quantum yield which is near unity. Rhodamine has been used as a marker in a wide variety of enyzmic activity studies (serine protease 6 , esterase 7 , caspase 8 , DT diaphorase 9 ). Essentially the NH 2 groups of rhodamine 110 are conjugated to a polypeptide, which mimics the natural substrate of the enzyme in question.
Upon cleavage of the polypeptide mimic, the rhodamine is released and in aqueous solution undergoes a conversion to a highly fluorescent zwitterionic form. The change in rhodamine's fluorescence quantum yield from its unconjugated (lactone form), to conjugated (zwitterionic form) is considerable (Rho 110 φ lactone = 0.006 φ zwitterion = 0.98). This sharp increase in fluorescence is easily detectable by even handheld instruments and often just the naked eye. This paper considers the previous synthetic literature for rhodamine 110 derivatives and reports on new exploratory approaches to the tailoring of this important fluorophore. Furthermore it addresses why rhodamine conjugates have not been more widely applied to pathogen detection via bacterial enzymatic action.
The most recent review of rhodamine 110 details the methodology used for the synthesis of rhodamine derivatives, which is essentially unchanged since the 1980's.
Rhodamine 110 is reacted with a protected amino acid, which is first activated with a coupling agent. Following deprotection and subsequent activation, further amino acids are added in a routine fashion, however the yields are often poor and the costs of the initial rhodamine are high (£100/g). In addition, there is no mention of racemisation in any of the seminal work, on which that review is based.
original literature dealing with biologically relevant rhodamine conjugates, we observe multiple discrepancies between the compounds reported and the fluorescence data before and after enzymatic cleavage. There is no reported yield for the cathepsin C activated rhodamine 12 or caspase conjugates 8 , yet these are reportedly known in various reviews. The synthesis of the serine protease activated rhodamine by Mangel et al is also highly improbable in its simplicity and purification via centrifuge. 11 The only characterisation undertaken is TLC and low resolution MS. The elemental analysis deviates from the empirical formula, but water and HCl are inexplicably added to bring the observed values within tolerance. The absence of HPLC/NMR facilities when the work was done in 1982 means that it is unlikely the compound was specifically synthesised. The primary literature reports the (CBz-Arg) 2 -Rhodamine to be a pink powder, yet the Sinclair group reported a white solid after HPLC purification. The biological testing of the serine protease activated rhodamine as then reported bears out the fact that whatever was synthesised is impure. The UV-Vis spectra indicates there is still fluorescence of the rhodamine conjugate at 525nm. If the fluorescence quantum yield alone is three orders of magnitude lower for a Bis-NH 2 conjugated rhodamine than for the free fluorophore, this fluorescence should not be visible, yet it is shown to be fluorescent in the original paper from 1982. The conclusion has to be that a mixture of rhodamine, mono Arg-Rhodamine and bis Arg-Rhodamine was in fact made. Thus the contrast between conjugated and unconjugated rhodamine is comparatively small and significant amounts of protease are required to achieve this. As a consequence, any attempt to achieve a high sensitivity e.g. for the detection of pM concentrations of an enzyme expressed by a pathogen would be met with failure.
As indicated in the previous section rhodamine conjugates have been somewhat overlooked as the fluorescent component for practical enzymatic tests and there is a need to develop synthetic methodology to tune the rhodamine structure efficiently.
Previously reported synthesis has proven capricious with initial coupling reactions of amino acids with rhodamine being of very low yield and this makes them less amenable to scale-up. We discuss the different approaches and show an improvement in the overall yield of a recently reported rhodamine conjugate (Boc-ValPro-Arg) 2 -Rhodamine (1), which has shown remarkable selectivity and sensitivity for MRSA and MSSA as reported by the authors. 
Results

The xanthone approach
Grignard
The main problem with functionalising the NH 2 groups on rhodamine are the intrinsic lack of nucleophilicity of these, due to resonance and other effects. 13 To overcome this problem the approach was taken to reduce some of the possible conjugation through the rhodamine via removal of the top lactone aromatic. The aim was to achieve a better amino acid coupling yield and introduce the lactone ring at a later stage. The method followed that of A.
Young-Hoon et al whom originally developed the procedure to produce library of rosamines for combinatorial synthesis. These conditions were adapted to produce the initial required nitro amino xanthone (3) for further modification towards a number of novel unsymmetrical rhodamines for further study. Having functionalised the NH 2 of xanthone 3 with an appropriately protected amino acid e.g. N-BocArginine(Cbz) 2 -OH to give 4, the upper ring system could be introduced using a Grignard type approach as indicated in Figure 4 .
Whilst the test reaction of phenyl magnesium bromide and unfunctionalised xanthone 6 successfully produced tertiary alcohol 7 ( Figure 4 (b)), the Grignard reaction using acetal protected benzaldehyde on nitro amino xanthone 3 was unsuccessful in the production of 8, further elaboration to 9 and 10 were therefore not possible ( Figure 4 (c)). Upon examination of the crude mixture, the expected signals were observed neither by NMR nor by MS, instead we obtained a complex and intractable mixture of deeply purple coloured products which could not be successfully isolated and characterised. Figure 4 . Proposed incorporation of C ring using Grignard followed by mild oxidation.
The reaction was tested a number of times with varying excesses of Grignard reagent without generating the product of interest (See Table SI -4) . This result warranted further investigation, upon which the Bartoli indole synthesis was implicated. This synthesis detailed the reaction of vinyl Grignard reagents with aryl nitro compounds, demonstrating the reactivity of the aryl nitro group towards Grignard reagents. 15 It is possible that attack on the deactivated ketone group of the xanthone was slower than on the nitro group demonstrating the incompatibility of nitro arenes with Grignard reagents, aiding explanation of the observed results.
Samarium Iodide
During the investigation into new routes towards non-commercially available Rhodamine dye analogues, the reducing agent samarium iodide (SmI 2 ) was noticed. Attention was given to this due to its ability to produce γ-lactones via the reductive coupling of α, β-unsaturated esters with carbonyl compounds, and the broad scope provided by this ability. The process by which these systems were formed starts with a carbonyl such as a ketone or aldehyde, which is reduced to form a ketyl type radical. The unsaturated compound then acts as a radicalophile to form the first bond with the ketyl radical, cyclisation follows. As a variety of γ-lactones couple in this way, investigation into the production of these lactones from more complex substrates such as xanthone was carried out. The reductive cyclisation test of cyclohexanone (11) shown in Figure 5 (a) was carried out successfully to produce 12, (See SI -5) however, when applied to our xanthone (6) even after 20 hours at room temperature there had been no reaction or indication of 13. The reaction was repeated under reflux conditions and the number of equivalents of SmI 2 increased from 2.5 to 5. This was to address the possibility of the commercially obtained SmI 2 solution being of lower concentration than that stated, which is widely mentioned in literature regarding its use. 13 Subsequent reactions involved freshly prepared SmI 2 solution produced from Imamoto's method, standardised under nitrogen against a known volumetric solution of ultra-pure iodine in THF (See Table SI -6) . 17, 18 Following standardisation of the freshly prepared SmI 2 solution, further reactions were performed: two at room temperature for 20 hours as before, using precisely 2.5 equivalents of SmI 2 : one of which with, and one without the s-Butanol additive. This would compare with previous attempts so as to rule out the possibility of the reaction being unsuccessful due to inconsistent SmI 2 solution concentrations, or indeed the inclusion of the alcohol proton donor additive which is usually required for this type of reductive coupling. 
In the presence of the s-Butanol, xanthene was produced in the reaction mixture ( Figure 6 ), implying that the carbonyl was simply reduced down to a CH 2 , but also indicates that xanthone is incompatible with the reductive coupling and thus unable to produce rhodamine analogues 13 -16 ( Figure 5 (b) & (c)), conceivably due to stabilisation of the ketyl radical species formed in the first step.
Directed metalation
As one of the better known routes to aryl containing structures, directed metalation was investigated in the context of rhodamine conjugate synthesis. The Wuts group explored the use of dialkyl hydrazides as directed lithiating agents and this showed promise. 20 Their work addressed the difficulty found when hydrolysing amidetype directed metalating agents and found that hydrazides were more favourable. Secondary butyllithium (s- This demonstrated the viability of the directed metalation approach for the production of further rhodamine analogues 22, 23 (Figure 7(c) ), however the reaction proved intolerant of the amino/nitro arrangement ( Figure   7(d) ).
Improvement to standard peptide chemistry
Optimising coupling agents and conditions
The ability to scale-up the synthesis of rhodamine conjugates for affordable, real-world application had, at that point not been achieved, and we turned our attention back to the original coupling approaches to the rhodamine 110 core structure (2).
The problems associated with the coupling of arginine to rhodamine are a useful exemplar reaction to the coupling of any amino acid to rhodamine. In respect of the steric bulk, nucleophilicity and basic nature of the guanidinium side-chain moiety (leading to possible side-reactions) on the arginine, this combination represents the worst-case scenario for such a coupling. A variety of different coupling agents and protecting groups were used (Table 1) and it was possible to optimise the conditions to obtain an initial coupling yield of 25%.This was achieved when using the powerful coupling agent HATU, which has been shown to be effective in difficult couplings especially with sterically hindered amino acids. 21, 22 Equally as important, the yield was consistent throughout several runs and represents a sound method for scaling the initial coupling.
Coupling Reagent Isolated yield EEDQ
- PPh 3 Cl - EDCI/Oxyma 5% COMU 8% HATU 25% M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Scale-up problems with deprotection of Cbz groups
The previously reported synthesis of (Boc-Val-Pro-Arg) 2 -Rhodamine involves the direct attachment of an exhaustively CBz protected Boc-arginine with a particularly poor yield (17%), with subsequent amino acids being added prior to deprotection via hydrogenation. However, this approach is not amenable to scale-up and larger amounts of (Boc-Val-Pro-Arg(CBz) 2 ) 2 -Rhodamine cannot be successfully deprotected either by using standard or non-standard hydrogenation techniques. This is evidenced in a report by Peakdale Molecular Ltd, which can be found in supporting information (SI -10 and SI -11). Indeed, the rate of hydrogenation of the central benzyl ester was shown to be greater for (Boc-Val-Pro-Arg(CBz) 2 ) 2 -Rhodamine (1) than rate of loss of the Cbz groups ( Figure 8 ). and Lactone formation using DDQ and the reduced (Boc-Val-Pro-Arg) 2 
-Rhodamine derivative (25).
For the real world application of (Boc-Val-Pro-Arg) 2 -Rhodamine (1) to the in situ detection of S. aureus in both clinical and non clinical environments, the final CBz deprotection step and its selectivity is critical and equally applicable to the development of other protease probes containing the CBz protecting group. This is because the hydrogenated lactone (25) is not fluorescent and so its liberation upon cleavage of the peptide side chain produces no fluorescence contrast change, rendering the probe ineffective.
Since all hydrogenation steps failed to selectively remove the CBz groups and leave the central lactone intact when scaled up, an alternative approach was adopted. If we cannot avoid the loss of the lactone, would it be possible to reform the required functionality after exhaustive hydrogenation (removing the Cbz groups and opening up the lactone to give 25) through subsequent oxidation? The oxidant 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) was selected for its oxidative coupling ability and a test reaction was set up to be monitored by proton NMR. Dissolution of the inactivated product in MeOD with an excess of DDQ allowed reaction progress to be monitored by proton NMR at 1 minute intervals. 23 We were delighted to observe the reappearance of the lactone functionality through disappearance of the signal for the benzylic proton in question.
This method was then applied to a scaled up completion of the synthesis, using 8 equivalents of DDQ in MeOH, it was possible to reform the central lactone of the rhodamine core ( Figure 8 ) to yield 1.
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The yield of this reaction is high (83%) and the correct structure was verified with NMR and HR MS (See SI -12 & SI -13). Details of the synthetic chemistry, including general experimental spectroscopic data are available in supplementary information.
Biological Testing For Surface Detection
Preparation of bacterial samples
Clinical isolates of MRSA, MSSA, S. epidermidis and E. coli, were revived from -80°C and cultured overnight on Brain Heart Infusion (BHI) agar at 37°C, followed by two subcultures on nutrient agar. For each experiment, an inoculum of a respective bacterial species was cultured overnight in 100 mL nutrient broth under shaking conditions, and each bacterial sample was then washed with 1 x phosphate buffered saline (PBS) by centrifugation at 4000 rpm, and bacterial concentrations of 10 4 , 10 3 and 10 2 colony forming units per ml (CFU mL -1 ), were created by serial dilution of the bacteria in 1x PBS.
Co-cultures of varying ratios of MRSA/MSSA with S. epidermidis and E. coli were produced using the relative cell count percentages as detailed in the table below (Table 2) . A  20 %  10%  70%  B  20 %  20%  60%  C  20 %  30%  50%  D  20 %  40%  40%  E  20 %  50%  30%  F  20 %  60%  20%  G  20 %  70%  10%  Table 2 . Bacterial co-culture ratios designated A-G Stainless steel coupons were washed, rinsed and placed in a glass petri dish followed by sterilisation using an autoclave. These were placed in an incubator overnight to ensure thorough drying of each plate. A bacterial inoculum of a single strain of MRSA or MSSA, in addition to S. epidermidis and E. coli, was cultured overnight in 100 mL nutrient broth. A 4 mL aliquot of each bacterial suspension was then cultured in 100 mL nutrient broth aerobically for 4 hours under shaking conditions. Each bacterial sample was harvested by centrifugation at 4000 rpm and washed with 1 x Phosphate buffered saline (PBS), and bacterial concentrations of 10 4 , 10 3 and 10 2 M A N U S C R I P T
Co-culture MRSA or MSSA S. epidermidis E.coli
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CFU mL -1 were generated by serial dilution of bacteria in 1x PBS supplemented with 10 % heat inactivated fetal bovine serum (FBS).
A 50 µL aliquot of each bacterial sample was pipetted aseptically onto the steel coupons, and these were incubated aerobically overnight at 37°C. A cotton wool swab soaked in PBS was then used to remove the bacteria, and this was placed in an Eppendorf tube with 100 µL of sterile PBS, the tube was then vortexed to dislodge bacteria from the swab.
This was performed twice: once with using the LGX test (using a 100 µM LGX solution), and once using bacterial culture to determine cell viability. Swabbing was performed as described above in the experimental section. This process was repeated 3 times and the results shown in Figure 9 and 10 are averages with standard deviation error bars.
Preparation of LGX
A 100 µM and 50 µM solution of LGX was prepared by dissolving fluorophore 1 in 2. 
Discussion
As can be observed, the majority of samples test positive for MRSA (denoted by a fluorescence reading exceeding 20,000 RFU). Figure 7 demonstrates the effects of co-culturing E. coli and S. epidermidis on the efficacy of detecting MRSA using the LGX system. The graph depicts the mean fluorescence response of 2 strains of MRSA tested on separate occasions. However, it is noted that the presence of FBS in the experimental system may interfere with the fluorescence potential of LGX, and this requires further investigation. Figure 8 demonstrates the effects of co culturing E. coli and S. epidermidis and MSSA (a coagulase positive organism) on the efficacy of detecting MSSA using the LGX system (ratios of MSSA/MRSA with contaminating organisms can be found in Table 2 ). As with MRSA (Figure 8 
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Highlights
• Scale-up of a rapid, simple fluorescence test for MRSA/MSSA is reported for the first time.
• MRSA/MSSA was detectable in our test despite the presence of contaminating bacterial strains (E. coli and S. epidermidis) • The co-culturing evaluation demonstrates the potential application of LGX to surface detection of MRSA/MSSA in the 'real world' scenario.
